These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Diagnosis and treatment of obstetric thrombohemorrhagic syndrome]. Grigorian AA; Avanesian RM; Melkonian VK Zh Eksp Klin Med; 1974; 14(4):96-103. PubMed ID: 4547478 [No Abstract] [Full Text] [Related]
3. [Inhibition of the thromboplastic effect of placental extracts using trasylol]. Slunsky R Z Geburtshilfe Perinatol; 1972 Jun; 176(3):201-6. PubMed ID: 4538438 [No Abstract] [Full Text] [Related]
5. [The effect of protamine sulfate on blood coagulation in intravenous administration of placental extract]. Skipetrov VP Patol Fiziol Eksp Ter; 1966; 10(4):69-70. PubMed ID: 5237748 [No Abstract] [Full Text] [Related]
6. [Significance of intravascular blood coagulation in the pathogenesis of pregnancy complications]. Kiriushchenkov AP; Bokarev IN; Makatsariia AD Akush Ginekol (Mosk); 1977 Mar; (3):1-4. PubMed ID: 331983 [No Abstract] [Full Text] [Related]
7. [The effect of placentin-3--a new preparation from human placental tissue--on the blood coagulating system]. Limvinov VV Biull Eksp Biol Med; 1969 Feb; 67(2):19-21. PubMed ID: 5821421 [No Abstract] [Full Text] [Related]
8. Inhibition of coagulation by fibrinopeptides released during fibrinolysis. Schneider CL; Engstrom RM Bibl Anat; 1969; 10():469-73. PubMed ID: 5407402 [No Abstract] [Full Text] [Related]
9. [THE THROMBOPLASTIC ACTIVITY OF THE AMNIOTIC FLUID AND OF THE PLACENTAL EXTRACT IN FULL-TERM PREGNANCIES]. SLUNSKY R Z Geburtshilfe Gynakol; 1963 Sep; 161():56-65. PubMed ID: 14093618 [No Abstract] [Full Text] [Related]
10. Fibrinogen turnover during the administration of high phospholipidic content placental extracts. Casale G; Ricotti MP; Caliandro LP Farmaco Prat; 1977 Jun; 32(6):312-7. PubMed ID: 872919 [No Abstract] [Full Text] [Related]
11. Immediate effect of components from the interior of human cells on blood coagulation. Clarke N; Collins M Ir J Med Sci; 1971 Feb; 140(2):60-70. PubMed ID: 5575703 [No Abstract] [Full Text] [Related]
12. [Prevention and treatment of blood coagulation disorders in pregnancy toxemias]. Soszka T Ginekol Pol; 1981 Jan; 52(2):201-4. PubMed ID: 7019013 [No Abstract] [Full Text] [Related]
13. [Pathogenesis and the principles of prevention and therapy of various types of coagulopathy in obstetrical practice (clinical lecture)]. Makatsariia AD; Mukhitdinova TK; Mishchenko AL; Aleev SN Akush Ginekol (Mosk); 1990 Jun; (6):11-6. PubMed ID: 2221255 [No Abstract] [Full Text] [Related]
14. [The effect of hyaluronidase on blood coagulation and bleeding time]. Slunsky R Zentralbl Gynakol; 1970 Dec; 92(50):1668-71. PubMed ID: 5491525 [No Abstract] [Full Text] [Related]
15. [The effect of cortisone on the blood coagulation system in women with nephropathy in pregnancy]. Belousov GV; Golubev AP; Karpushin VP Akush Ginekol (Mosk); 1966 Mar; 42(3):22-8. PubMed ID: 5983248 [No Abstract] [Full Text] [Related]
16. [Significance of adrenaline and thyroxine in the development of the thrombohemorrhagic syndrome]. Georgieva SA; Golovchenko VM; Gladilin GP; Kirichuk VF; Tokaeva LK Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):35-7. PubMed ID: 7413624 [No Abstract] [Full Text] [Related]
17. [Heparin therapy of pregnant women with placental insufficiency]. Makatsariia AD; Mishchenko AL; Kazakova LA; Kiriushchenkov PA Akush Ginekol (Mosk); 1989 Aug; (8):30-3. PubMed ID: 2817276 [TBL] [Abstract][Full Text] [Related]